122 related articles for article (PubMed ID: 35118463)
21. Intracerebral administration of recombinant rabies virus expressing GM-CSF prevents the development of rabies after infection with street virus.
Wang H; Zhang G; Wen Y; Yang S; Xia X; Fu ZF
PLoS One; 2011; 6(9):e25414. PubMed ID: 21980450
[TBL] [Abstract][Full Text] [Related]
22. GM-CSF: Orchestrating the Pulmonary Response to Infection.
McCormick TS; Hejal RB; Leal LO; Ghannoum MA
Front Pharmacol; 2021; 12():735443. PubMed ID: 35111042
[TBL] [Abstract][Full Text] [Related]
23. Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model.
Hernandez-Ilizaliturri FJ; Jupudy V; Reising S; Repasky EA; Czuczman MS
Leuk Lymphoma; 2005 Dec; 46(12):1775-84. PubMed ID: 16263581
[TBL] [Abstract][Full Text] [Related]
24. Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis.
Sainathan SK; Hanna EM; Gong Q; Bishnupuri KS; Luo Q; Colonna M; White FV; Croze E; Houchen C; Anant S; Dieckgraefe BK
Inflamm Bowel Dis; 2008 Jan; 14(1):88-99. PubMed ID: 17932977
[TBL] [Abstract][Full Text] [Related]
25. Recombinant human granulocyte macrophage-colony stimulating factor expressed in yeast (sargramostim): A potential ally to combat serious infections.
Damiani G; McCormick TS; Leal LO; Ghannoum MA
Clin Immunol; 2020 Jan; 210():108292. PubMed ID: 31676420
[TBL] [Abstract][Full Text] [Related]
26. G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.
Martinez Sanz P; van Rees DJ; van Zogchel LMJ; Klein B; Bouti P; Olsman H; Schornagel K; Kok I; Sunak A; Leeuwenburg K; Timmerman I; Dierselhuis MP; Kholosy WM; Molenaar JJ; van Bruggen R; van den Berg TK; Kuijpers TW; Matlung HL; Tytgat GAM; Franke K
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049929
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection.
Sasaki Md; Foccacia R; de Messias-Reason IJ
Vaccine; 2003 Nov; 21(31):4545-9. PubMed ID: 14575766
[TBL] [Abstract][Full Text] [Related]
28. Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.
Criner GJ; Lang FM; Gottlieb RL; Mathews KS; Wang TS; Rice TW; Madduri D; Bellam S; Jeanfreau R; Case AH; Glassberg MK; Lyon GM; Ahmad K; Mendelson R; DiMaio JM; Tran MP; Spak CW; Abbasi JA; Davis SG; Ghamande S; Shen S; Sherman L; Lowry S
Am J Respir Crit Care Med; 2022 Jun; 205(11):1290-1299. PubMed ID: 35290169
[No Abstract] [Full Text] [Related]
29. Granulocyte macrophage colony-stimulating factor has come of age: From a vaccine adjuvant to antiviral immunotherapy.
Petrina M; Martin J; Basta S
Cytokine Growth Factor Rev; 2021 Jun; 59():101-110. PubMed ID: 33593661
[TBL] [Abstract][Full Text] [Related]
30. Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma.
Smith II JW; Kurt RA; Baher AG; Denman S; Justice L; Doran T; Gilbert M; Alvord WG; Urba WJ
J Immunother; 2003; 26(2):130-8. PubMed ID: 12616104
[TBL] [Abstract][Full Text] [Related]
31. GM-CSF: A Double-Edged Sword in Cancer Immunotherapy.
Kumar A; Taghi Khani A; Sanchez Ortiz A; Swaminathan S
Front Immunol; 2022; 13():901277. PubMed ID: 35865534
[TBL] [Abstract][Full Text] [Related]
32. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome.
Aggarwal A; Baker CS; Evans TW; Haslam PL
Eur Respir J; 2000 May; 15(5):895-901. PubMed ID: 10853855
[TBL] [Abstract][Full Text] [Related]
33. Block of Granulocyte-Macrophage Colony-Stimulating Factor Prevents Inflammation-Induced Preterm Birth in a Mouse Model for Parturition.
Nold C; Stone J; O'Hara K; Davis P; Kiveliyk V; Blanchard V; Yellon SM; Vella AT
Reprod Sci; 2019 Apr; 26(4):551-559. PubMed ID: 30296925
[TBL] [Abstract][Full Text] [Related]
34. GM-CSF in the lung protects against lethal influenza infection.
Huang FF; Barnes PF; Feng Y; Donis R; Chroneos ZC; Idell S; Allen T; Perez DR; Whitsett JA; Dunussi-Joannopoulos K; Shams H
Am J Respir Crit Care Med; 2011 Jul; 184(2):259-68. PubMed ID: 21474645
[TBL] [Abstract][Full Text] [Related]
35. A randomized, placebo-controlled trial of granulocyte-macrophage colony-stimulating factor and nucleoside analogue therapy in AIDS.
Brites C; Gilbert MJ; Pedral-Sampaio D; Bahia F; Pedroso C; Alcantara AP; Sasaki MD; Matos J; Renjifo B; Essex M; Whitmore JB; Agosti JM; Badaro R
J Infect Dis; 2000 Nov; 182(5):1531-5. PubMed ID: 11023477
[TBL] [Abstract][Full Text] [Related]
36. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages.
O'Mahony DS; Pham U; Iyer R; Hawn TR; Liles WC
Int J Med Sci; 2008 Jan; 5(1):1-8. PubMed ID: 18219369
[TBL] [Abstract][Full Text] [Related]
37. Chronic pharmacological antagonism of the GM-CSF receptor in mice does not replicate the pulmonary alveolar proteinosis phenotype but does alter lung surfactant turnover.
Corkill DJ; Hunt AN; Hinrichs MJ; White N; Rebelatto M; Roskos L; Nys J; Scott A; Robinson MJ; Ryan P; Postle AD; Sleeman MA
Clin Sci (Lond); 2021 Nov; 135(22):2559-2573. PubMed ID: 34778899
[TBL] [Abstract][Full Text] [Related]
38. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
39. Effect of GM-CSF on immune, inflammatory, and clinical responses to ragweed in a novel mouse model of mucosal sensitization.
Cates EC; Gajewska BU; Goncharova S; Alvarez D; Fattouh R; Coyle AJ; Gutierrez-Ramos JC; Jordana M
J Allergy Clin Immunol; 2003 May; 111(5):1076-86. PubMed ID: 12743573
[TBL] [Abstract][Full Text] [Related]
40. Sargramostim and immune checkpoint inhibitors: combinatorial therapeutic studies in metastatic melanoma.
Tarhini AA; Joshi I; Garner F
Immunotherapy; 2021 Aug; 13(12):1011-1029. PubMed ID: 34157863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
